IGIgor A. Glushakov

Igor A. Glushakov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Igor A. Glushakov has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Features of the course of the early period of primary tuberculosis infection in a patient with Hurler syndrome: tactics of managing a comorbid patient

    by I. A. Glushakov, M. E. Lozovskaya, O. I. Gumeniuk

    A clinical case of a child with comorbid pathology demonstrates the high importance of alertness of specialists of various profiles of the pediatric network. Doctors of the pediatric phthisiology network are of no small importance, since in children with genetic diseases, tuberculosis can proceed under the «masks» of other pathologies. Mucopolysaccharidosis type I (MPS I) is a rare genetic disease caused by a mutation of the IDUA gene, which encodes the enzyme alpha-L-iduronidase. Hurler syndrome, which is the most severe form of MPS I, requires special attention to prevent the development of severe complications, which often lead to death.

  • Integrated approach to care of children with genetic disorders on the example of a child with A pert syndrome (clinical case)

    by Igor A. Glushakov, Olga I. Gumenyuk, Darya A. Tyapkina, Gadzhikerim E. Gadzhikerimov, Yuri V. Chernenkov

    The article presents a clinical case of Apert syndrome in a 2-year-old child. Apert syndrome is an auto-somal dominant hereditary craniosynostosis that develops due to the pathogenic variant of the FGFR2 gene, which leads to a deficiency of intracellular signals that regulate embryogenesis, causing premature gastrulation, implantation abnormalities, violation of epithelial-mesenchymal interactions, which determines the severity of the patient's condition. The article demonstrates an integrated approach to the management and observation of such a patient with the involvement of specialists of various profiles.

  • Open Access

    Genetic aspects of taste formation

    by O. I. Gumeniuk, M. E. Lobanov, T. E. Posled, E. M. Chursina, Yu. V. Chernenkov, O. S. Groznova, I. A. Glushakov

    The article discusses the molecular genetic basis of taste development which determines the peculiarity of perception of sweet, salty, sour, bitter and high-protein food (umami). The genes TAS1R3, FTO, GLUT2, FGF21, GNAT3 are responsible for individual perception of sugar volume. Serum FGF21 levels are significantly elevated in obese patients and in patients with type 2 diabetes mellitus which presumably indicates a state of resistance to FGF21. Given the role of refined sugars in the development of diseases, the use of foods with a reduced content or complete absence of added sugar is a worldwide trend, especially necessary in the nutrition of children. During genome-wide sequencing for 39 patients aged 15-18 years, FGF21 gene polymorphism was detected in 27 adolescents (69 %) without gender identity. Almost all patients with FGF21 gene polymorphism showed a high addiction to sweet foods. Currently, the existence of a sixth taste is being debated, it is ammonium chloride, whose receptors are regulated by the Otop1 gene which is also responsible for the identification of sour taste.

  • Open Access

    Digestive system and mitochondrial diseases in children

    by O. I. Gumeniuk, I. A. Glushakov, Yu. V. Chernenkov, I. A. Bochkarev, G. V. Gafurova, E. E. Sukhushina

    The article discusses the features of lesions of the digestive system in children with mitochondrial diseases. Mitochondria play an important role in cellular metabolism as they are responsible for producing the majority of cellular energy in the form of adenosine triphosphate. Mutations in mitochondrial genes responsible for the functioning of mitochondria can lead to various forms of mitochondrial diseases. These diseases may present with the following clinical symptoms: muscle weakness, movement disorders, neurological symptoms, impaired motility and absorption from the gastrointestinal tract. Diagnosis of mitochondrial diseases can be challenging due to genetic and clinical heterogeneity. Treatment currently remains a pressing problem, as research in this area is being actively conducted and new methods are emerging aimed at the therapy and treatment of these rare diseases.


  • The significance of preventive treatment for tuberculosis infection in children

    by Igor A. Glushakov, Marina E. Lozovskaya, Mikhail G. Gutkin, Elena B. Vasilyeva, Yulia A. Yarovaya

    Objective: to evaluate the value of tuberculosis preventive treatment (PTT) in children with tuberculosis infection. Material and methods. As part of a continuous study, a cohort of 200 children from 1 to 17 years old taken for clinical observation in group VI A (positive test result with the recombinant tuberculosis allergen [ATR]) was analyzed. All children underwent additional examination methods to exclude the local form of tuberculosis: physical examination, laboratory clinical and biochemical tests of blood and urine, multislice computed tomography of the chest organs and, according to clinical recommendations, PTT was proposed, which the parents of 65 children refused. Study groups: 1 — those with no family contact with a patient with tuberculosis (ТВ) (n=70): 2 — those with contact with a patient with ТВ (n=65), in group 3 included children whose parents refused PTT, despite the presence of indications (n=65), incl. 14 children were from Tl lesions. Children group 1 and 2 received PTT. Control over the PTT was carried out on the "Yandex.Teleconference". Results. As a result of comparison of the three groups, reliable data were obtained on the effectiveness of PTT according to the criteria of preventing the disease and reducing the results of the ATR test. A significantly high percentage of sick children in group 3 was established, compared with children from group 1 (p=0.008; x2=18.6). When assessing the dynamics of the results of immunodiagnostic tests in children of the group 1 who received PTT, a decrease in the test with ATR was significantly more often observed compared to children without PTT(p=0.001; x2=17.2). It is worth noting that children had satisfactory tolerability of the drugs; no adverse events were observed in patients with daily video recording. Conclusion. A conclusion was made about the need for preventive work with parents of children who refused preventive treatment to increase their level of adherence, the need to evaluate the effectiveness of PTT courses using primary and additional criteria, including the importance of controlled PTT.

  • Open Access

    Mucopolysaccharidosis Type I (Hurler – Scheie Syndrome): Case Report

    by Nato D. Vashakmadze, Olga I. Gumenuyk, Yuri V. Chernenkov, Ekaterina Yu. Zacharova, Igor A. Glushakov, Е. Ю. Захарова

    Background. Mucopolysaccharidosis type I (MPS I) is an inherited disease caused by pathogenic variants in the IDUA gene, which encodes the lysosomal enzyme alpha-L-iduronidase. This clinical case demonstrates the importance of diagnosing rare diseases when patients have phenotypic features indicating hereditary pathology presence. Phenotype changes can be so-called “red flag” that helps specialists suspect and diagnose lysosomal storage diseases. Clinical case description. The patient was observed with delayed psychomotor development; she also had hepatomegaly and on auscultation of the heart there was a functional systolic murmur above the apex and in the Botkin–Erb point on heart auscultation. Coarse “garholoid” facial features attracted attention at external examination: large nose, wide sunken nose bridge, macroglossia, thick lips, synophrysis, scaphocephaly, wide chest, and flat-valgus feet. Echocardiography has revealed mitral valve insufficiency and hardened valve leaflets. Ophthalmologist examination: hypermetropic astigmatism. Psychiatrist examination: mental and speech development delay. Enzymatic diagnostics: significant decrease in alpha-Liduronidase activity. No further examinations were carried out due to the onset of the COVID-19 epidemic and parents' doubts about the diagnosis. The patient was readmitted to the hospital at the age of 6 years due to aggravation of her condition. A molecular genetic study has revealed two pathogenic variants in the IDUA gene. Diagnosis of MPS I was established according to the clinical data, results of biochemical and molecular genetic studies. Conclusion. This clinical case demonstrates the classic course of MPS I with typical phenotypic signs and lesions in various organs and systems. The presented case demonstrates the importance of professional vigilance among doctors of various specialties regarding orphan diseases.